Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
US pharma giant Pfizer (NYSE: PFE) has struck a commercialization deal with Chinas Sciwind Biosciences for the GLP-1 drug Xianyida (ecnoglutide), gaining exclusive rights in mainland China in a pact worth up to $495 million
Results of the multicenter spaniel trial (MUST): taurine- and carnitine-responsive dilated cardiomyopathy in American cocker spaniels with decreased plasma taurine concentration
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound)
5c-d), there was no change in the beneficial effect on glycaemia of Ex4 injection into the OB indicating that PNS activity was not implicated in the beneficial effects of Ex4 administration in the OB
